Evidence map›Paper›PMID 36068204›Full record

ArticleNature communications2022

MVsim is a toolset for quantifying and designing multivalent interactions.

Bence Bruncsics, Wesley J Errington, Casim A Sarkar

Abstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Multivalency Enables Signal Processing at Single Protein Level.Journal of the American Chemical Society · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

  • Update of
    2021
5 · Who and what money

Authors and funding

3 authors.

Bence Bruncsics *Department of Measurement and Information Systems, Budapest University of Technology and Economics, Budapest, H-1111, Hungary.
Wesley J Errington *Department of Biomedical Engineering, University of Minnesota, Minneapolis, MN, 55455-0215, USA.ORCID 0000-0003-4246-7402
Casim A SarkarDepartment of Biomedical Engineering, University of Minnesota, Minneapolis, MN, 55455-0215, USA. csarkar@umn.edu.ORCID 0000-0002-0276-8203

Funding

Analysis and Engineering of Cell SignalingR35GM136309 · NIGMS · UNIVERSITY OF MINNESOTA · PI Casim Sarkar · 2020 to 2026
$2.3M
Interplay between signaling and noise in cellular decision makingR01GM113985 · NIGMS · UNIVERSITY OF MINNESOTA · PI SARKAR, CASIM · 2015 to 2019
$1.7M
Rapid discovery of new biologics and cell-surface targets to direct cell behaviorR21EB022258 · NIBIB · UNIVERSITY OF MINNESOTA · PI SARKAR, CASIM · 2016 to 2017
$402k
Biacore T200 surface plasmon resonance instrumentS10OD021539 · OD · UNIVERSITY OF MINNESOTA · PI HAWKINSON, JON E · 2016 to 2016
$344k
NIBIB NIH HHS R21 EB022258NIGMS NIH HHS R01 GM113985NIGMS NIH HHS R35 GM136309NIH HHS S10 OD021539
6 · The paper itself

Abstract

Arising through multiple binding elements, multivalency can specify the avidity, duration, cooperativity, and selectivity of biomolecular interactions, but quantitative prediction and design of these properties has remained challenging. Here we present MVsim, an application suite built around a configurational network model of multivalency to facilitate the quantification, design, and mechanistic evaluation of multivalent binding phenomena through a simple graphical user interface. To demonstrate the utility and versatility of MVsim, we first show that both monospecific and multispecific multivalent ligand-receptor interactions, with their noncanonical binding kinetics, can be accurately simulated. Further, to illustrate the conceptual insights into multivalent systems that MVsim can provide, we apply it to quantitatively predict the ultrasensitivity and performance of multivalent-encoded protein logic gates, evaluate the inherent programmability of multispecificity for selective receptor targeting, and extract rate constants of conformational switching for the SARS-CoV-2 spike protein and model its binding to ACE2 as well as multivalent inhibitors of this interaction. MVsim and instructional tutorials are freely available at https://sarkarlab.github.io/MVsim/ .

Indexed as

COVID-19HumansLigandsProtein BindingSARS-CoV-2Spike Glycoprotein, CoronavirusLigandsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID36068204
PMCPMC9448752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.